CoChat

Update on the heritability of inflammatory bowel disease: The importance of twin studies

Open access
Brant, Steven R. · 2011 · Inflammatory Bowel Diseases
Cited by 123

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Initial reports of familial clustering of inflammatory bowel disease (IBD), i.e., families with multiple relatives with Crohn's disease (CD) or ulcerative colitis (UC), suggested that these relatively uncommon disorders might be due to substantial genetic effects. Case series later showed that IBD risk to relatives of IBD probands (first person with IBD identified in a family) far exceeded that expected for relatively uncommon disorders. For example, in one of the first population-based studies of familial IBD, Orholm et al1 observed that the risk of CD to first-degree relatives of CD patients was 10-fold greater and the risk of UC to relatives of UC patients was 8-fold greater than the risk of CD or UC to first-degree relatives of healthy controls. Additionally, CD and UC appeared genetically related, as CD risk for a relative of a UC case was 2-fold greater and the opposite risk was 4-fold greater than that for individuals without an IBD family history. Nonetheless, detractors to theories of IBD having genetic origins noted that UC and CD incidence rates increased greatly—and steadily—each decade since first ascertained, far greater than could be accounted by greater disease recognition, and incidences differed widely by geography.2 Moreover, familial clustering might be due to environmental factors (e.g., predisposing microorganisms shared among relatives). However, long before the discovery of the now more than 40 established genes for CD and UC,3, 4 IBD case reports in monozygotic twins (MZ) suggested that IBD was unusually heritable, with 17 of 20 CD pairs and 5 of 11 UC pairs concordant for disease.5 The first study of IBD among unselected, population-based twins, the Swedish twin registry, provided the proof that IBD, particularly CD, was in large part due to major genetic risk factors—although the MZ twin concordance, with probands identified by discharge diagnoses in public hospitals and diagnoses confirmed by review of medical records, was far less than that suggested by the case reports in the literature.5 In 1988, Tysk et al5 identified 34 MZ and 43 same-sex dizygotic (DZ) twins with at least one diagnosis of CD or UC. Among the 18 MZ twins with a CD proband, eight were concordant for CD; among the 26 DZ twins with a CD proband, only one was concordant (Table 1). In contrast, the observed MZ and DZ concordance for UC was 6.3% and 0%, respectively. As noted by the authors, the CD heritability of liability estimate of 1.0 (95% confidence interval [CI] 0.80–1.0) was higher and the UC estimate of 0.53 (95% CI 0.24–0.82) similar to concurrent estimates reported for diabetes (0.77), hypertension (0.57), or asthma (0.29). IBD Reported in Published Studies of Unselected Twin Cohorts IBD Reported in Published Studies of Unselected Twin Cohorts The remarkably greater MZ compared to DZ concordance for CD can only be explained by genetic factors: while both twin types are born at the same time and had all been reared in the same environment, MZ twins are essentially human clones of each other, having originated from the same zygote and thus having inherited the identical genetic material from both their mothers and fathers. DZ twin pairs are genetically as related as non-twin sibling pairs and will inherit the identical copy of any given gene from their mother or their father only 50% of the time. Additionally, the incomplete concordance among MZ twins suggested that within the same general environment, specific environmental or other acquired risk factors either trigger CD or UC in the affected twin, or perhaps for some factors, “protect” the unaffected twin. For example, in an investigation that utilized Swedish and Danish IBD twin cohorts, smoking was 5-fold protective of UC among discordant MZ twins.6 The Swedish twin registry findings of 1988 were a major incentive to proceed with molecular genetics research to identify genes for CD (which in turn has been one of the leading complex disorders to have susceptibility genes identified), and might have discouraged research to identify genes for UC. The twin cohorts that followed (Table 1) either supported the high CD concordance for MZ twins or observed a substantially reduced MZ twin concordance rate than the original Swedish twin study, whereas UC was observed to be more genetic.7,–10 Had the landmark, Swedish population-based twin study overestimated heritability of CD and underestimated that of UC, or was CD more genetic in the Scandinavian population as suggested by the Danish study that identified probands by questionnaires with a high rate of return mailed to a large twin registry? If anything, a longitudinal follow-up limited to the original Swedish IBD twins suggested that MZ concordance for both CD and UC was underestimated due to failure to diagnose or identify IBD: a co-twin suspected of having CD in the original study was formally diagnosed in 1992 (26 years after his brother was diagnosed with CD in 1966); a co-twin with insufficient evidenc

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ibd.21385

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Brant, S. R.
Venue
Inflammatory Bowel Diseases
Published
2011-01
Volume
17
Issue
1
Pages
1-5
ISSN
1078-0998 (ISSN-L)
OpenAlex
W2033275384
Cited by
123
References
2
FWCI
3.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.